Structure ofCampylobacter jejuniLipopolysaccharides Determines Antiganglioside Specificity and Clinical Features of Guillain-Barré and Miller Fisher Patients
Open Access
- 1 March 2002
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 70 (3) , 1507-1517
- https://doi.org/10.1128/iai.70.3.1202-1208.2002
Abstract
Ganglioside mimicry in the lipopolysaccharide (LPS) fraction ofCampylobacter jejuniisolated from Guillain-Barré syndrome (GBS) and Miller Fisher syndrome (MFS) patients was compared with isolates from patients with an uncomplicated enteritis. The antibody response toC. jejuniLPS and gangliosides in neuropathy patients and controls was compared as well. LPS from GBS and MFS-associated isolates more frequently contained ganglioside-like epitopes compared to control isolates. Almost all neuropathy patients showed a strong antibody response against LPS and multiple gangliosides in contrast to enteritis patients. Isolates from GBS patients more frequently had a GM1-like epitope than isolates from MFS patients. GQ1b-like epitopes were present in all MFS-associated isolates and was associated with anti-GQ1b antibody reactivity and the presence of oculomotor symptoms. These results demonstrate that the expression of ganglioside mimics is a risk factor for the development of post-Campylobacterneuropathy. This study provides additional evidence for the hypothesis that the LPS fraction determines the antiganglioside specificity and clinical features in post-Campylobacterneuropathy patients.Keywords
This publication has 46 references indexed in Scilit:
- A case of Guillain-Barré syndrome following a family outbreak of Campylobacter jejuni enteritisJournal of Neuroimmunology, 2000
- Monoclonal antibodies raised against Guillain-Barré syndrome–associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparationsJournal of Clinical Investigation, 1999
- Ganglioside GM1 Mimicry inCampylobacterStrains from Sporadic Infections in the United StatesThe Journal of Infectious Diseases, 1999
- Campylobacter jejuni infections and anti‐GM1 antibodies in guillain‐barré syndromeAnnals of Neurology, 1996
- A somatically mutated human antiganglioside IgM antibody that induces experimental neuropathy in mice is encoded by the variable region heavy chain gene, V1-18.Journal of Clinical Investigation, 1996
- Chemical Structures of the Core Region of Campylobacter Jejuni O:3 Lipopolysaccharide and an Associated PolysaccharideEuropean Journal of Biochemistry, 1995
- Serum anti‐GQ1b IgG antibodies recognize surface epitopes on Campylobacter jejuni from patients with Miller Fisher syndromeAnnals of Neurology, 1995
- Molecular mimicry between GQ1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fisher's syndromeAnnals of Neurology, 1994
- Cloning of human anti‐GM1 antibodies from motor neuropathy patientsAnnals of Neurology, 1994
- Human serum antibody response inCampylobacter jejuni enteritis as measured by enzyme-linked immunosorbent assayEuropean Journal of Clinical Microbiology & Infectious Diseases, 1988